SKY92

Medical diagnostic reagents for conducting molecular tests; molecular diagnostic reagents for testing of body substances, namely, bone marrow samples, blood samples, and on human or animal tissue, for medical purposes; molecular diagnostic reagents used to test for cancer for medical purposes; medical diagnostic preparations for use in molecular tests using microarray technology and sequencing technology; genetic identity tests comprised of reagents for medical purposes; preparations for detecting genetic predispositions, namely, for measurement of gene aberrations and mutations, for use with clinical multiplex test assays, and for the determination of the genetic sub-type of a patient; reagents for diagnostic medical testing; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids and tissues in connection with genetic tests, clinical tests, prognostic tests or predictive tests for use in disease detection, namely, hematological disorders; chemical preparations, for medical purposes, for the testing of blood and human or animal tissue for diagnostic purposes

Software featuring algorithms for performing diagnostic tests for medical purposes; software for generating and reading out of the genetic properties of a patient sample; software for interpreting and analyzing raw genetic data for use by laboratory users, molecular biologists, pathologists, physicians and patients, for determining the presence of a genetic aberration, mutation, or gene expression profile, genetic subtype of a disease or clinical consequence thereof and prognosis, whether or not in combination with a specific treatment; computer software for operation of a validated, secure IT infrastructure for clinical purposes; downloadable databases featuring anonymous genetic data of patients from clinical studies for comparison with the genetic outcome of patients samples; software operating and user manuals recorded on CDROMs featuring information on diagnostic testing

Scientific research and development of molecular diagnostic tests; developing software to perform diagnostic tests for medical purposes; development of software, algorithms and databases for translating, analyzing and interpreting test results; molecular diagnostic analysis for scientific research purposes; research and analysis of bodily tissue and fluids and molecular diagnostic test scores for the purpose of developing new biomarkers, testing, and methods of treatment of diseases and disorders; leasing of computer software for reading test results; development, standardization and validation of molecular diagnostic tests; genetic testing for scientific research purposes

Medical analysis services for diagnostic and treatment purposes; analysis of medical and veterinary test scores and data for others for diagnostic and treatment purposes; providing medical and veterinary information; genetic testing for medical purposes; conducting medical tests to determine a patient's prognosis in connection with a disease; providing predictive medical testing for assessing the effectiveness of a medical treatment or to select the medical treatment